Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-26-220695
Filing Date
2026-05-13
Accepted
2026-05-13 08:33:22
Documents
1
Period of Report
2025-12-31
Effectiveness Date
2026-05-13

Document Format Files

Seq Description Document Type Size
1 ARS d845755dars.pdf ARS 2122413
  Complete submission text file 0001193125-26-220695.txt   2924296
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-41583 | Film No.: 26971079
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)